Perrigo Acquires Omega Pharma For $4.5B

November 9, 2014 | Perrigo, and international pharmaceutical company on the Tel Aviv Stock Exchange, acquired Belgian Omega Pharma for $4.5 billion. Perrigo is one of the world’s largest private labels for the manufacture and sale of over-the-counter drugs and Omega is a specialist, selling over 2,000 different kinds of over-the-counter pharmaceuticals to chains and drug stores worldwide. The announcement came as Perrigo reported positive fourth financial quarter results, with $952 million in revenue. Perrigo acquired Agis Industries, an Israeli-based generic pharmaceutical company, in 2005 for $850 million.